HAVN Life Sciences Inc. (HAVLF) est une société cotée en bourse dans le Santé secteur, opérant dans le Biotechnologie secteur d'activité. Le siège social de l'entreprise est situé à Port Moody, BC, Canada. Le PDG actuel est Tim Moore.
HAVLF a date d'introduction en bourse 2021-01-08, 6 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $2.57K.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
